Subtype
Kidney and Ureter Neoplasm
CI-CAN-00001051Explore in graph →
Non-malignant518 active trials17 approved drugs81 evidence items
- NCIt
- C7514
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001051Explore in graph →
Clinical trials
2,410 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02326558 | Comparison of Microwave Ablation-Assisted Enucleation and Conventional Laparoscopic Partial Nephrectomy in the Treatment of T1a Renal Cell Carcinoma | completed | N/A | 183 | RenJi HospitalOTHER | 1 | Apr 5, 2017 | clinicaltrials |
| NCT01557127 | Nexavar Dosing in Renal Cancer Patients in "Real-life" Setting(NEXST) | completed | — | 205 | BayerINDUSTRY | 1 | Mar 28, 2017 | clinicaltrials |
| NCT00244764 | GW786034 In Subjects With Locally Recurrent Or Metastatic Clear Cell Renal Cell Carcinoma | completed | Phase 2 | 225 | GlaxoSmithKlineINDUSTRY | 8 | Mar 27, 2017 | clinicaltrials |
| NCT00807339 | CyberKnife for Unresectable Renal Tumors | completed | N/A | 17 | Beth Israel Deaconess Medical CenterOTHER | 1 | Mar 21, 2017 | clinicaltrials |
| NCT01751529 | Open-label Pilot Evaluating Renal Lesions w/ Contrast-enhaced US in Patients w/ Renal Cancer | completed | Early Phase 1 | 48 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Mar 17, 2017 | clinicaltrials |
| NCT00630409 | Phase II Clinical Trial of Gemcitabine and Doxil® for Metastatic Renal Cell Carcinoma | completed | Phase 2 | 5 | University of PittsburghOTHER | 1 | Mar 10, 2017 | clinicaltrials |
| NCT01141569 | A Study of RO4929097 in Patients With Advanced Renal Cell Carcinoma That Have Failed Vascular Endothelial Growth Factor (VEGF)/Vascular Endothelial Growth Factor Receptor (VEGFR) Therapy | completed | Phase 2 | 12 | National Cancer Institute (NCI)NIH | 1 | Mar 10, 2017 | clinicaltrials |
| NCT02685553 | Near Infrared Technology and Laparoscopic Resection of Pancreatic Lesions: the COLPAN Project | completed | Phase 1 | 10 | Universita di VeronaOTHER | 1 | Mar 7, 2017 | clinicaltrials |
| NCT00617253 | Combination of Recombinant Human IL-21 (rIL-21) and Sunitinib in Stage IV Renal Cell Carcinoma Patients | completed | Phase 2 | 9 | Novo Nordisk A/SINDUSTRY | 2 | Mar 1, 2017 | clinicaltrials |
| NCT02607553 | Safety and Activity of G-202 in Patients With Clear Cell Renal Cell Carcinoma That Expresses PSMA | completed | Phase 2 | 2 | GenSpera, Inc.INDUSTRY | 1 | Feb 24, 2017 | clinicaltrials |
| NCT00418496 | Interleukin-2 With Sorafenib (BAY 43-9006) for Unresectable or Metastatic Clear Cell Renal Carcinoma (RCC) and Metastatic Melanoma | completed | Phase 1 | 17 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Feb 20, 2017 | clinicaltrials |
| NCT02677337 | NCCN Renal Cell Registry | completed | N/A | 120 | Duke UniversityOTHER | 1 | Feb 17, 2017 | clinicaltrials |
| NCT00957424 | Acceptability of Less Harmful Alternatives to Cigarettes | completed | N/A | 67 | Roswell Park Cancer InstituteOTHER | 1 | Feb 7, 2017 | clinicaltrials |
| NCT00423332 | Cediranib (AZD2171, RECENTIN™) in Metastatic or Recurrent Renal Cell Carcinoma | completed | Phase 2 | 105 | AstraZenecaINDUSTRY | 2 | Feb 2, 2017 | clinicaltrials |
| NCT02143492 | Tumor Collection From Routine Nephrectomy for Subjects With Advanced Stage RCC | completed | — | 11 | Argos TherapeuticsINDUSTRY | 1 | Jan 24, 2017 | clinicaltrials |
| NCT00003657 | High-dose ICE With Amifostine | completed | Phase 2 | 24 | Dana-Farber Cancer InstituteOTHER | 1 | Jan 20, 2017 | clinicaltrials |
| NCT00256880 | Pazopanib (GW786034) In Subjects With Relapsed Or Refractory Multiple Myeloma | completed | Phase 2 | 100 | GlaxoSmithKlineINDUSTRY | 2 | Jan 18, 2017 | clinicaltrials |
| NCT01328574 | TRC105 in Adults With Advanced/Metastatic Urothelial Carcinoma | completed | Phase 2 | 13 | National Cancer Institute (NCI)NIH | 1 | Jan 13, 2017 | clinicaltrials |
| NCT02334709 | Phase I/II Trial of Stereotactic Body Radiotherapy With Concurrent Fixed Dose Tyrosine Kinase Inhibitors in Metastatic Renal Cell Carcinoma: Dose Limiting Toxicity and Abscopal Effect. | completed | Phase 1 / Phase 2 | 13 | University Hospital, GhentOTHER | 1 | Jan 11, 2017 | clinicaltrials |
| NCT02829775 | A Study of Continued Treatment Among Participants Who Have Responded to Peginterferon Alfa-2a (Pegasys®) or Recombinant Interferon Alfa-2a (Roferon-A®) in Prior Clinical Studies | completed | Phase 2 / Phase 3 | 9 | Hoffmann-La RocheINDUSTRY | 7 | Jan 9, 2017 | clinicaltrials |
| NCT00003126 | Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer | completed | Phase 3 | 69 | Loyola UniversityOTHER | 1 | Jan 4, 2017 | clinicaltrials |
| NCT00172003 | Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone Metastasis | completed | Phase 4 | 50 | Novartis PharmaceuticalsINDUSTRY | 1 | Nov 18, 2016 | clinicaltrials |
| NCT00943839 | Sunitinib Malate in Treating Patients With Kidney Cancer | completed | N/A | 60 | Centre Antoine LacassagneOTHER | 1 | Nov 10, 2016 | clinicaltrials |
| NCT00903175 | Efficacy and Safety Comparison of RAD001 Versus Sunitinib in the First-line and Second-line Treatment of Patients With Metastatic Renal Cell Carcinoma(RECORD-3) | completed | Phase 2 | 471 | Novartis PharmaceuticalsINDUSTRY | 19 | Nov 8, 2016 | clinicaltrials |
| NCT01392729 | An Observational Study of Avastin (Bevacizumab) and Interferon Alpha 2a in Patients With Metastatic Renal Cell Cancer (VERA) | completed | — | 40 | Hoffmann-La RocheINDUSTRY | 1 | Nov 2, 2016 | clinicaltrials |
| NCT01585974 | Duration of Treatment With Tyrosine Kinase Inhibitors in the Treatment of Metastatic Renal Cell Carcinoma(TURCOS) | completed | — | 151 | BayerINDUSTRY | 1 | Oct 19, 2016 | clinicaltrials |
| NCT01522820 | Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors | completed | Phase 1 | 18 | Roswell Park Cancer InstituteOTHER | 1 | Oct 4, 2016 | clinicaltrials |
| NCT00310115 | Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy | completed | — | 469 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 23, 2016 | clinicaltrials |
| NCT01283048 | Bevacizumab and BKM-120 in Patients With Metastatic Renal Cell Carcinoma | completed | Phase 1 | 32 | Toni Choueiri, MDOTHER | 1 | Sep 21, 2016 | clinicaltrials |
| NCT00126594 | Sorafenib Tosylate With or Without Recombinant Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer | completed | Phase 2 | 80 | National Cancer Institute (NCI)NIH | 1 | Sep 16, 2016 | clinicaltrials |
| NCT00365768 | Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors | completed | Phase 2 | 56 | Columbia UniversityOTHER | 1 | Sep 9, 2016 | clinicaltrials |
| NCT02627144 | Bevacizumab in Metastatic Renal Cancer | completed | — | 365 | Hoffmann-La RocheINDUSTRY | 1 | Aug 29, 2016 | clinicaltrials |
| NCT01808079 | Gene Analysis in Studying Susceptibility to Wilms Tumor | completed | — | 1 | Children's Oncology GroupNETWORK | 1 | Aug 22, 2016 | clinicaltrials |
| NCT02862288 | Preliminary Study of Microwave Tumoral Ablation Performances for the Treatment of Pulmonary, Renal and Bone Neoplasia.(TherMO) | completed | Phase 1 / Phase 2 | 30 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Aug 11, 2016 | clinicaltrials |
| NCT01442090 | Study of GDC-0980 Versus Everolimus in Participants With Metastatic Renal Cell Carcinoma Who Have Progressed on or Following Vascular Endothelial Growth Factor- (VEGF) Targeted Therapy | completed | Phase 2 | 85 | Genentech, Inc.INDUSTRY | 5 | Aug 10, 2016 | clinicaltrials |
| NCT01404104 | Neo-adjuvant Temsirolimus in Patients With Advanced Renal Cell Carcinoma | completed | N/A | 11 | St. Joseph's Healthcare HamiltonOTHER | 1 | Jul 27, 2016 | clinicaltrials |
| NCT00027573 | Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Unresectable Kidney Cancer | completed | Phase 2 | 36 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 14, 2016 | clinicaltrials |
| NCT00042965 | Capecitabine and Gemcitabine in Treating Patients With Metastatic Kidney Cancer | completed | Phase 2 | 60 | Alliance for Clinical Trials in OncologyOTHER | 2 | Jul 14, 2016 | clinicaltrials |
| NCT01553175 | Studying Gene Expression in Samples From Patients With Rhabdoid Tumors | completed | — | 25 | Children's Oncology GroupNETWORK | 0 | Jul 14, 2016 | clinicaltrials |
| NCT01576198 | Studying Biomarkers in Samples From Younger Patients With Wilms Tumor | completed | — | 2,227 | Children's Oncology GroupNETWORK | 0 | Jul 14, 2016 | clinicaltrials |
| NCT00006483 | Sargramostim in Treating Patients With Kidney Cancer That Has Spread to the Lung | completed | Phase 2 | 27 | Alliance for Clinical Trials in OncologyOTHER | 2 | Jul 13, 2016 | clinicaltrials |
| NCT01353300 | Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer | completed | — | 31 | Children's Oncology GroupNETWORK | 0 | Jul 11, 2016 | clinicaltrials |
| NCT01550393 | Biomarkers in Urine Samples From Patients With Wilms Tumor | completed | — | 100 | Children's Oncology GroupNETWORK | 0 | Jul 11, 2016 | clinicaltrials |
| NCT00072046 | Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer) | completed | Phase 3 | 732 | Alliance for Clinical Trials in OncologyOTHER | 2 | Jul 6, 2016 | clinicaltrials |
| NCT00738530 | A Study of Avastin (Bevacizumab) Added to Interferon Alfa-2a (Roferon) Therapy in Patients With Metastatic Renal Cell Cancer With Nephrectomy | completed | Phase 3 | 649 | Hoffmann-La RocheINDUSTRY | 18 | Jun 23, 2016 | clinicaltrials |
| NCT01155258 | Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors | completed | Phase 1 | 19 | University of Southern CaliforniaOTHER | 1 | Jun 13, 2016 | clinicaltrials |
| NCT00465179 | Sunitinib Malate in Patients With Non-Clear Cell Renal Cell Cancer | completed | Phase 2 | 61 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 7, 2016 | clinicaltrials |
| NCT01491672 | Everolimus as Second-line Therapy in Metastatic Renal Cell Carcinoma(RECORD-4) | completed | Phase 2 | 134 | Novartis PharmaceuticalsINDUSTRY | 6 | Jun 6, 2016 | clinicaltrials |
| NCT00088803 | DNA Variations in the Gene in Young Patients With Wilms' Tumor | completed | — | 471 | Children's Oncology GroupNETWORK | 7 | May 19, 2016 | clinicaltrials |
| NCT01118078 | Biomarkers in Tissue Samples From Patients With High-Risk Wilms Tumor | completed | — | 185 | Children's Oncology GroupNETWORK | 1 | May 19, 2016 | clinicaltrials |
Data updated 23 days agoSource updated Apr 5, 2017source: clinicaltrials